Crossvault Capital Management LLC Gilead Sciences, Inc. Transaction History

Crossvault Capital Management LLC

$254 Million
Q2 2022

A detailed history of Crossvault Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Crossvault Capital Management LLC holds 20,295 shares of GILD stock, worth $1.83 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

20,295

Previous 21,895 7.31%

Holding current value

$1.83 Million

Previous $1.3 Million 3.69%

% of portfolio

0.49%

Previous 0.42%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $92,352 - $104,016	-1,600 Reduced 7.31%	20,295 $1.25 Million
Q1 2022 May 05, 2022	SELL	$57.92 - $72.58 $210,249 - $263,465	-3,630 Reduced 14.22%	21,895 $1.3 Million
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $207,616 - $235,648	3,200 Added 14.33%	25,525 $1.85 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $27,076 - $29,212	400 Added 1.82%	22,325 $1.56 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $100,028 - $109,295	-1,576 Reduced 6.71%	21,925 $1.5 Million
Q1 2021 Apr 28, 2021	SELL	$60.0 - $68.46 $54,000 - $61,613	-900 Reduced 3.69%	23,501 $1.52 Million
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $165,701 - $188,808	-2,925 Reduced 10.7%	24,401 $1.42 Million
Q3 2020 Oct 21, 2020	BUY	$62.1 - $78.08 $16,767 - $21,081	270 Added 1.0%	27,326 $1.73 Million
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $19,965 - $23,184	276 Added 1.03%	27,056 $2.08 Million
Q1 2020 Apr 17, 2020	SELL	$62.63 - $80.22 $283,463 - $363,075	-4,526 Reduced 14.46%	26,780 $2 Million
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $566,904 - $623,576	-9,200 Reduced 22.71%	31,306 $2.03 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $128,895 - $142,278	2,062 Added 5.36%	40,506 $2.57 Million
Q1 2019 Apr 24, 2019	SELL	$62.53 - $70.05 $143,819 - $161,115	-2,300 Reduced 5.65%	38,444 $2.5 Million
Q4 2018 Jan 30, 2019	SELL	$60.54 - $79.0 $440,610 - $574,962	-7,278 Reduced 15.16%	40,744 $2.55 Million
Q3 2018 Oct 24, 2018	SELL	$71.28 - $78.92 $149,901 - $165,968	-2,103 Reduced 4.2%	48,022 $3.71 Million
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $4,866 - $5,676	-75 Reduced 0.15%	50,125 $3.55 Million
Q1 2018 Apr 25, 2018	SELL	$72.84 - $88.8 $52,809 - $64,380	-725 Reduced 1.42%	50,200 $3.79 Million
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $1.54 Million - $1.81 Million	-21,625 Reduced 29.81%	50,925 $3.65 Million
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $5.23 Million - $6.2 Million	72,550	72,550 $5.88 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossvault Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crossvault Capital Management LLC with notifications on news.

Account

Crossvault Capital Management LLC Gilead Sciences, Inc. Transaction History